The Significance of Pertechnetate Uptake in Assessing Response to Radioiodine Therapy in Patients With Hyperthyroidism

Authors

  • Milan Lomigora Faculty of Medicine, University of Priština temporarily settled in Kosovska Mitrovica Author
  • Srđan Petković Faculty of Medicine, University of Priština temporarily settled in Kosovska Mitrovica Author
  • Strahinja Jevtić Faculty of Medicine, University of Priština temporarily settled in Kosovska Mitrovica Author

Keywords:

hyperthyroidism, pertechnetate uptake, thyroid scintigraphy, radioiodine therapy, hypothyroidism

Abstract

Introduction: Radioiodine therapy is a nuclear medicine treatment for hyperthyroidism based on the selective accumulation of radioactive iodine in functioning thyroid tissue. Assessment of thyroid functional status is an important part of the pre-treatment evaluation. Pertechnetate uptake (TcP) is determined by thyroid scintigraphy and reflects thyroid functional activity.
Aim: To investigate the association of pertechnetate uptake with biochemical indicators of thyroid function, administered therapeutic radioiodine activity, and the time required to achieve hypothyroidism following radioiodine therapy.
Material and Methods: The study included 69 patients, 16 men (23.2%) and 53 women (76.8%), with a mean age of 56.8±13.8 years. The mean administered therapeutic activity was 361 MBq. Thyroid scintigraphy with measurement of pertechnetate uptake was performed 30 minutes after intravenous administration of the radiopharmaceutical, with uptake determined using dedicated gamma-camera software. Spearman’s correlation coefficient, the Mann–Whitney U test, and the Wilcoxon test were used. Statistical significance was set at p<0.05.
Results: No statistically significant association was found between pertechnetate uptake and the administered therapeutic activity (r=0.127; p=0.323). A moderate positive correlation was found between age and the time required to achieve hypothyroidism (r=0.394; p=0.016). Pertechnetate uptake was negatively correlated with TSH levels (r=-0.300; p=0.026), whereas positive correlations were observed with fT3 (r=0.437; p=0.025) and fT4 levels (r=0.304; p=0.023).
Conclusion: Pertechnetate uptake was significantly associated with selected biochemical indicators of thyroid function, whereas its association with the administered therapeutic activity was not statistically significant. These findings highlight the importance of functional thyroid assessment before therapy and support further investigation of the prognostic value of pertechnetate uptake.

Published

2026-11-18

Issue

Section

Abstracts